|
REV3L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.322000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.262200E-02 |
| Normal-vs-Stage2 |
2.920400E-01 |
| Normal-vs-Stage3 |
3.086400E-01 |
| Normal-vs-Stage4 |
6.065000E-01 |
| Stage1-vs-Stage2 |
8.394200E-01 |
| Stage1-vs-Stage3 |
9.605000E-01 |
| Stage1-vs-Stage4 |
4.272800E-01 |
| Stage2-vs-Stage3 |
9.060600E-01 |
| Stage2-vs-Stage4 |
7.102800E-01 |
| Stage3-vs-Stage4 |
6.078800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.126160E-02 |
| Normal-vs-AfricanAmerican |
4.097700E-02 |
| Normal-vs-Asian |
4.635600E-01 |
| Caucasian-vs-AfricanAmerican |
8.108400E-01 |
| Caucasian-vs-Asian |
2.412400E-01 |
| AfricanAmerican-vs-Asian |
1.498430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.844000E-03 |
| Normal-vs-Female |
5.619900E-02 |
| Male-vs-Female |
5.148800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.353000E-01 |
| Normal-vs-Extreme_Weight |
1.494370E-01 |
| Normal-vs-Obese |
7.818000E-03 |
| Normal-vs-Extreme_Obese |
5.776400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.487800E-01 |
| Normal_Weight-vs-Obese |
5.336100E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.069400E-01 |
| Extreme_Weight-vs-Obese |
9.814300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.407000E-01 |
| Obese-vs-Extreme_Obese |
4.176400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.226300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.550800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.001980E-01 |
| Normal-vs-Age(81-100Yrs) |
4.277400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.731000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.299000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.720300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.004400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.920400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.794810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.36029999999277E-05 |
| Normal-VS-Type2 PRCC |
3.122000E-01 |
| Normal-VS-KIRP CIMP |
1.355180E-01 |
| Normal-VS-Unclassified PRCC |
3.378000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.48779999934001E-08 |
| Type1 PRCC-VS-KIRP CIMP |
1.840180E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.815000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.306300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.157200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.372200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.650000E-01 |
| Normal-vs-N1 |
6.186200E-02 |
| Normal-vs-N2 |
1.887380E-01 |
| N0-vs-N1 |
3.008100E-02 |
| N0-vs-N2 |
3.769600E-01 |
| N1-vs-N2 |
3.896600E-03 |
|
|
